netbook
desktop
mobile
tablet-landscape
tablet
phone-landscape
phone
Research to Prevent Blindness

Age-Related Macular Degeneration


Click on the image, above, to watch RPB's online educational event, "RPB Lunch & Learn: Eye on AMD," featuring RPB-supported researchers giving an overview of AMD disease pathology and treatment options, as well as providing insight into new research directions. 

Hope Through Research

RPB researchers are working to understand and prevent macular degeneration, to halt its progression, and to develop optical devices to offset vision loss. Each year, RPB dedicates hundreds of thousands of dollars to AMD research.

Age-related macular degeneration (AMD) is a vision disorder caused by abnormalities in a portion of the eye's retina called the macula. Early symptoms of AMD are blurred central vision and a waviness of straight lines. The blurriness may progress to blind spots, affecting reading, TV watching and many other pleasures of independent living. There are two stages of AMD. Early AMD is far more common but late AMD has a far greater impact on vision.

Late AMD can be subdivided into the dry, or non-neovascular, form and the wet, or neovascular, form (see illustration). Dry AMD is characterized by more extensive pigmentary abnormalities in the macula and by a somewhat extensive loss of pigment cells and vision cells in the central macula.  It is called dry because it is not associated with abnormal blood vessels or leakage of blood or fluid.

View Video

Click one of the video selections to view.

An estimated 1.75 million Americans over age 40 have decreased vision from AMD.  That number is expected to increase to 3 million by 2020.

 

Wet AMD occurs in about 10% of patients who have late AMD. It is characterized by an overgrowth of blood vessels, behind the macula, that leak blood or fluid or both. This leads to damage of the vision cells. Age is the single greatest risk factor for macular degeneration. Leaky blood vessels under the macula can cause changes in vision.  Studies supported by RPB show that lifestyle choices may influence the onset and progression of AMD.

Order RPB Eye Disease Fact Sheets

Related News: Macular Degeneration

Dr. Frans Vinberg

RPB Funding Helps Researchers Revive Light-Sensing Cells in Organ Donor Eyes

This ground-breaking research accomplishment will open new doors for research on neurodegenerative diseases like AMD.

Read More

 
Photo of eye
Watch The Video

Recording available: RPB webinar on Dry AMD and Geographic Atrophy

RPB grantees provide expert insight on geographic atrophy and dry AMD as part of the "Lunch & Learn" series.

Read More

 
Photo of eye

Join Us for AMD Awareness Month

Join RPB and Apellis Pharmaceuticals for a virtual event on Feb. 25 to learn about cutting-edge research into geographic atrophy and dry AMD.

Read More

 
Photo of eye
Watch The Video

Dry AMD Virtual Event

RPB grantees provide expert advice on dry AMD as part of the "Lunch & Learn" series.

Read More

 
Watch The Video

RPB Hosts Virtual AMD Event

RPB grantees provide expert advice on AMD as part of the "Lunch & Learn" series.

Read More

 
Dr. Semenza and colleague work in his lab

Research to Prevent Blindness Grantee Dr. Gregg Semenza Wins Nobel Prize in Medicine

Dr. Semenza is being recognized for his discoveries related to how cells respond to low oxygen levels, which have implications for the treatment of cancer, eye diseases and more.

Read More

 

Subscribe

Get our email updates filled with the latest news from our researchers about preventing vision loss, treating eye disease and even restoring sight. Unsubscribe at any time. Under our privacy policy, we'll never share your contact information with a third party.